Ovation Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Ovation Pharmaceuticals Ownership

Who owns Ovation Pharmaceuticals?

Ovation Pharmaceuticals is owned by H. Lundbeck A/S. It was acquired on March 19, 2009.

Was Ovation Pharmaceuticals formerly PE-backed?

Yes. Ovation Pharmaceuticals was formerly owned by 1 private investor.

Ovation Pharmaceuticals Business Overview

Where is Ovation Pharmaceuticals headquartered?

Ovation Pharmaceuticals is headquartered in Deerfield, Illinois.

What sector is Ovation Pharmaceuticals in?

Ovation Pharmaceuticals is a life science company.

When was Ovation Pharmaceuticals founded?

Ovation Pharmaceuticals was founded in 2000.

Life Science M&A Summary in 2009

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Ovation Pharmaceuticals, Inc.

Deerfield, Illinois
United States,
www.ovationpharma.com

Ovation Pharmaceuticals is a specialty pharmaceutical company focused on acquiring underpromoted branded pharmaceutical products and promising late-stage development products. Ovation increases the sales of its acquired products through the implementation of active selling efforts, creative marketing programs, and through product life cycle activities that are focused on developing new formulations, new indications, and other product improvements. Ovation is led by CEO Jeff Aronin and Executive Chairman Bill Gantz.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.